Cargando…
Evaluation of Serum Interleukin-6 and C-reactive Protein Levels in Drug-naïve Major Depressive Disorder Patients
Background Major depressive disorder (MDD) is a disabling health problem with a very high global prevalence and burden. Alteration of inflammatory markers in depression is of growing interest to many psychiatry researchers. This study aimed to examine the serum levels of interleukin-6 (IL-6) and C-r...
Autores principales: | Nishuty, Nuruna Lovely, Khandoker, Md. Mehedi Hasan, Karmoker, James Regun, Ferdous, Sumiya, Shahriar, Mohammad, Qusar, M.M.A. Shalahuddin, Islam, Md. Saiful, Kadir, Mohammad Fahim, Islam, Md Rabiul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414189/ https://www.ncbi.nlm.nih.gov/pubmed/30899619 http://dx.doi.org/10.7759/cureus.3868 |
Ejemplares similares
-
Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case–control study with or without antidepressant therapy
por: Emon, Md. Prova Zaman, et al.
Publicado: (2020) -
Evaluation of serum amino acids and non-enzymatic antioxidants in drug-naïve first-episode major depressive disorder
por: Islam, Md. Rabiul, et al.
Publicado: (2020) -
Community‐based decentralized mental health services are essential to prevent the epidemic turn of post‐Covid mental disorders in Bangladesh: A call to action
por: Islam, Md. Rabiul, et al.
Publicado: (2022) -
Evaluation of serum interleukin‐1 receptor antagonist levels in major depressive disorder: A case‐control study
por: Nahar, Zabun, et al.
Publicado: (2023) -
Higher serum interleukin‐12 levels are associated with the pathophysiology of major depressive disorder: A case‐control study results
por: Nahar, Zabun, et al.
Publicado: (2022)